These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28984362)

  • 1. A unique subphenotype of myasthenia gravis.
    Heckmann JM; Nel M
    Ann N Y Acad Sci; 2018 Jan; 1412(1):14-20. PubMed ID: 28984362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing identifies targets in the treatment-resistant ophthalmoplegic subphenotype of myasthenia gravis.
    Nel M; Jalali Sefid Dashti M; Gamieldien J; Heckmann JM
    Neuromuscul Disord; 2017 Sep; 27(9):816-825. PubMed ID: 28673556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravis.
    Nel M; Prince S; Heckmann JM
    Orphanet J Rare Dis; 2019 Jan; 14(1):24. PubMed ID: 30696470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis.
    Europa TA; Nel M; Heckmann JM
    Orphanet J Rare Dis; 2020 Dec; 15(1):346. PubMed ID: 33308266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Whole Genome Sequencing in an African Subphenotype of Myasthenia Gravis to Generate a Pathogenetic Hypothesis.
    Nel M; Mulder N; Europa TA; Heckmann JM
    Front Genet; 2019; 10():136. PubMed ID: 30881381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The African-387 C>T TGFB1 variant is functional and associates with the ophthalmoplegic complication in juvenile myasthenia gravis.
    Nel M; Buys JM; Rautenbach R; Mowla S; Prince S; Heckmann JM
    J Hum Genet; 2016 Apr; 61(4):307-16. PubMed ID: 26632886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular muscles.
    Europa TA; Nel M; Heckmann JM
    Neuromuscul Disord; 2019 May; 29(5):381-387. PubMed ID: 31029532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.
    Europa TA; Nel M; Lebeko MR; Heckmann JM
    IBRO Neurosci Rep; 2022 Jun; 12():297-302. PubMed ID: 35746973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraocular Muscle Findings in Myasthenia Gravis Associated Treatment-Resistant Ophthalmoplegia.
    Rautenbach RM; Pillay K; Murray ADN; Heckmann JM
    J Neuroophthalmol; 2017 Dec; 37(4):414-417. PubMed ID: 28742638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Myasthenia.
    Al-Haidar M; Benatar M; Kaminski HJ
    Neurol Clin; 2018 May; 36(2):241-251. PubMed ID: 29655447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders.
    Keene KR; Notting IC; Verschuuren JJGM; Voermans N; de Keizer ROB; Beenakker JM; Tannemaat MR; Kan HE
    J Neuromuscul Dis; 2023; 10(5):869-883. PubMed ID: 37182896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudo-internuclear ophthalmoplegia with downshoot in myasthenia gravis.
    Jay WM; Nazarian SM; Underwood DW
    J Clin Neuroophthalmol; 1987 Jun; 7(2):74-6. PubMed ID: 2956287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Information furnished by electromyography of the ocular muscles during myasthenic ophthalmoplegias].
    PASSOUANT P; VIALLEFONT H; LETE E; COSTEAU J
    Rev Neurol (Paris); 1961 Feb; 104():147-52. PubMed ID: 13733183
    [No Abstract]   [Full Text] [Related]  

  • 14. The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.
    Heckmann JM; Europa TA; Soni AJ; Nel M
    Front Neurol; 2022; 13():834212. PubMed ID: 35280301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraocular muscle volume on time-of-flight magnetic resonance angiography in patients with myasthenia gravis.
    Chen P; Zhou Q; Zhao X; Chen Y; Lin Z; Wang M; Yang Z; Liu W
    Muscle Nerve; 2024 Sep; 70(3):379-386. PubMed ID: 38948953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital magnetic resonance imaging of extraocular muscles in chronic progressive external ophthalmoplegia: specific diagnostic findings.
    Ortube MC; Bhola R; Demer JL
    J AAPOS; 2006 Oct; 10(5):414-8. PubMed ID: 17070475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraocular muscle characteristics related to myasthenia gravis susceptibility.
    Liu R; Xu H; Wang G; Li J; Gou L; Zhang L; Miao J; Li Z
    PLoS One; 2013; 8(2):e55611. PubMed ID: 23409007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of the unique human extraocular muscle allotype by expression profiling.
    Fischer MD; Budak MT; Bakay M; Gorospe JR; Kjellgren D; Pedrosa-Domellöf F; Hoffman EP; Khurana TS
    Physiol Genomics; 2005 Aug; 22(3):283-91. PubMed ID: 15855387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis.
    MacLennan C; Beeson D; Buijs AM; Vincent A; Newsom-Davis J
    Ann Neurol; 1997 Apr; 41(4):423-31. PubMed ID: 9124798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis presenting as an isolated inferior rectus paresis.
    Spoor TC; Shippman S
    Ophthalmology; 1979 Dec; 86(12):2158-60. PubMed ID: 555807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.